NRx Pharmaceuticals (NRXPW) to Release Quarterly Earnings on Thursday

NRx Pharmaceuticals (NASDAQ:NRXPW) is anticipated to issue its resultson Thursday, March 26th. Analysts expect the company to announce earnings of $0.0075 per share and revenue of $7.5250 million for the quarter.

NRx Pharmaceuticals Stock Down 20.1%

Shares of NASDAQ NRXPW opened at $0.02 on Tuesday. The stock’s fifty day moving average price is $0.04 and its two-hundred day moving average price is $0.07. NRx Pharmaceuticals has a one year low of $0.01 and a one year high of $0.18.

NRx Pharmaceuticals Company Profile

NRx Pharmaceuticals, Inc is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for neuropsychiatric and neurodegenerative disorders. The company’s research pipeline includes small‐molecule candidates designed to address underlying pathophysiological mechanisms implicated in conditions such as Rett syndrome, Alzheimer’s disease and Long COVID. Leveraging a proprietary formulation and delivery approach, NRx seeks to advance compounds that have demonstrated safety in prior studies toward new indications with significant unmet medical need.

Among its lead programs, NRx is developing NP-120 (sarizotan) for the treatment of Rett syndrome, a rare genetic disorder that impacts brain development in young girls.